Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michihiko Kuwano

Showing results (71-80 of 145) with videos related to

Pageof 15
Sort By:
Virchows Archiv : an International Journal of Pathology|August 3, 2013
Peroxiredoxins, thioredoxin, and Y-box-binding protein-1 are involved in the pathogenesis and progression of dialysis-associated renal cell carcinomaFumiyoshi Fushimi, Kenichi Taguchi, Hiroto Izumi, et al.
Gynecologic Oncology|February 4, 2014
Nuclear Y-box-binding protein-1 is a poor prognostic marker and related to epidermal growth factor receptor in uterine cervical cancerShin Nishio, Kimio Ushijima, Tomohiko Yamaguchi, et al.
International Journal of Cancer|March 29, 2002
Increased expression of multidrug resistance-associated proteins in bladder cancer during clinical course and drug resistance to doxorubicinYasuhiro Tada, Morimasa Wada, Toshiro Migita, et al.
The Journal of Pathology|January 21, 2003
Nuclear expression of Y-box-binding protein-1 correlates with P-glycoprotein and topoisomerase II alpha expression, and with poor prognosis in synovial sarcomaYoshinao Oda, Yoshihiro Ohishi, Tsuyoshi Saito, et al.
Cancer Research|November 21, 2013
Circadian regulation of mTOR by the ubiquitin pathway in renal cell carcinomaHiroyuki Okazaki, Naoya Matsunaga, Takashi Fujioka, et al.
Cancer Research|October 21, 2010
Loss of PTEN expression by blocking nuclear translocation of EGR1 in gefitinib-resistant lung cancer cells harboring epidermal growth factor receptor-activating mutationsChizuko Yamamoto, Yuji Basaki, Akihiko Kawahara, et al.
The Journal of Pharmacy and Pharmacology|August 28, 2002
Contribution of P-glycoprotein to efflux of ramosetron, a 5-HT3 receptor antagonist, across the blood-brain barrierChika Yamamoto, Hideyasu Murakami, Noriko Koyabu, et al.
Hepatology (Baltimore, Md.)|October 24, 2002
Trafficking and functional defects by mutations of the ATP-binding domains in MRP2 in patients with Dubin-Johnson syndromeKenkichi Hashimoto, Takeshi Uchiumi, Toshikazu Konno, et al.
Human Pathology|October 6, 2009
N-myc downstream regulated gene-1/Cap43 may play an important role in malignant progression of prostate cancer, in its close association with E-cadherinYooHyun Song, Yoshinao Oda, Mikifumi Hori, et al.
International Journal of Cancer|December 21, 2004
ATP-binding cassette superfamily transporter gene expression in human soft tissue sarcomasYoshinao Oda, Tsuyoshi Saito, Naomi Tateishi, et al.
Pageof 15

Showing results (71-80 of 145) with videos related to

Sort By:
Pageof 15
Virchows Archiv : an International Journal of Pathology|August 3, 2013
Peroxiredoxins, thioredoxin, and Y-box-binding protein-1 are involved in the pathogenesis and progression of dialysis-associated renal cell carcinomaFumiyoshi Fushimi, Kenichi Taguchi, Hiroto Izumi, et al.
Gynecologic Oncology|February 4, 2014
Nuclear Y-box-binding protein-1 is a poor prognostic marker and related to epidermal growth factor receptor in uterine cervical cancerShin Nishio, Kimio Ushijima, Tomohiko Yamaguchi, et al.
International Journal of Cancer|March 29, 2002
Increased expression of multidrug resistance-associated proteins in bladder cancer during clinical course and drug resistance to doxorubicinYasuhiro Tada, Morimasa Wada, Toshiro Migita, et al.
The Journal of Pathology|January 21, 2003
Nuclear expression of Y-box-binding protein-1 correlates with P-glycoprotein and topoisomerase II alpha expression, and with poor prognosis in synovial sarcomaYoshinao Oda, Yoshihiro Ohishi, Tsuyoshi Saito, et al.
Cancer Research|November 21, 2013
Circadian regulation of mTOR by the ubiquitin pathway in renal cell carcinomaHiroyuki Okazaki, Naoya Matsunaga, Takashi Fujioka, et al.
Cancer Research|October 21, 2010
Loss of PTEN expression by blocking nuclear translocation of EGR1 in gefitinib-resistant lung cancer cells harboring epidermal growth factor receptor-activating mutationsChizuko Yamamoto, Yuji Basaki, Akihiko Kawahara, et al.
The Journal of Pharmacy and Pharmacology|August 28, 2002
Contribution of P-glycoprotein to efflux of ramosetron, a 5-HT3 receptor antagonist, across the blood-brain barrierChika Yamamoto, Hideyasu Murakami, Noriko Koyabu, et al.
Hepatology (Baltimore, Md.)|October 24, 2002
Trafficking and functional defects by mutations of the ATP-binding domains in MRP2 in patients with Dubin-Johnson syndromeKenkichi Hashimoto, Takeshi Uchiumi, Toshikazu Konno, et al.
Human Pathology|October 6, 2009
N-myc downstream regulated gene-1/Cap43 may play an important role in malignant progression of prostate cancer, in its close association with E-cadherinYooHyun Song, Yoshinao Oda, Mikifumi Hori, et al.
International Journal of Cancer|December 21, 2004
ATP-binding cassette superfamily transporter gene expression in human soft tissue sarcomasYoshinao Oda, Tsuyoshi Saito, Naomi Tateishi, et al.
Pageof 15